Optimized clinical randomized controlled trials designed for biomarker-guided antibiotics stewardship | Zendy

Wensen Chen | Zendy; Kai Zhang | Zendy; Yun Liu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Optimized clinical randomized controlled trials designed for biomarker-guided antibiotics stewardship

Author(s) -

Wensen Chen,

Kai Zhang,

Yun Liu

Publication year - 2020

Publication title -

annals of translational medicine

Language(s) - English

Resource type - Journals

eISSN - 2305-5847

pISSN - 2305-5839

DOI - 10.21037/atm.2020.01.67

Subject(s) - biomarker , antibiotics , stewardship (theology) , antibiotic stewardship , medicine , randomized controlled trial , clinical trial , intensive care medicine , medical physics , biology , microbiology and biotechnology , antibiotic resistance , biochemistry , politics , political science , law

Department of Infection Management, Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China; Pancreas Institute of Nanjing Medical University, Nanjing 210029, China; Department of Geriatrics Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China; School of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing 210029, China These authors contributed equally to this work. Correspondence to: Yun Liu, MD, PhD. Department of Geriatrics Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China; School of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing 210029, China. Email: 47437034@qq.com.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research